Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luh

Showing results (1451-1460 of 1,486) with videos related to

Pageof 149
Sort By:
Blood|April 7, 2010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring systemHsin-An Hou, Tai-Chung Huang, Liang-In Lin, et al.
American Journal of Hematology|April 12, 2014
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
Ebiomedicine|October 27, 2018
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, et al.
European Journal of Haematology|April 7, 2018
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Blood|August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsWen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 DataPo-Ren Hsueh, Lee-Jene Teng, Chun-Ming Lee, et al.
American Journal of Hematology|October 12, 2013
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
Cancer|April 10, 2004
Community-based multiple screening model: design, implementation, and analysis of 42,387 participantsTony Hsiu-Hsi Chen, Yueh-Hsia Chiu, Dih-Ling Luh, et al.
American Journal of Hematology|October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
Pageof 149

Showing results (1451-1460 of 1,486) with videos related to

Sort By:
Pageof 149
Blood|April 7, 2010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring systemHsin-An Hou, Tai-Chung Huang, Liang-In Lin, et al.
American Journal of Hematology|April 12, 2014
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
Ebiomedicine|October 27, 2018
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, et al.
European Journal of Haematology|April 7, 2018
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Blood|August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsWen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 DataPo-Ren Hsueh, Lee-Jene Teng, Chun-Ming Lee, et al.
American Journal of Hematology|October 12, 2013
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
Cancer|April 10, 2004
Community-based multiple screening model: design, implementation, and analysis of 42,387 participantsTony Hsiu-Hsi Chen, Yueh-Hsia Chiu, Dih-Ling Luh, et al.
American Journal of Hematology|October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
Pageof 149